Catalog BPC-157, TB-500, ARA-290, VIP, KPV and 3 synergistic formulations all verified by HPLC to purity 98%
The potential involvement of a dopaminergic mechanism in this process was inferred from the blocking action of pimozide, a dopamine antagonist, on the DSIP-induced GH increase
Preliminary research suggests interferential therapy may also be beneficial in individuals with irritable bowel syndrome (Coban 2012)
A change in a urinary metabolite cannot establish that a peptide treats chronic insomnia
[DOI] [PMC free article] [PubMed] [Google Scholar] 39.Gojkovic S., Krezic I., Vranes H., Zizek H., Drmic D., Horvat Pavlov K., Petrovic A., Batelja Vuletic L., Milavic M., Sikiric S., et al
This increases the risk of contamination , improper dosing, and adverse reactions due to inconsistent product quality